Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)

Sep. 2025Pharmacy Updates

Unichem Pharmaceuticals (USA), Inc. is recalling one lot, lot GMML24026A, of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. Cyclobenzaprine is used for the relief of muscle spasms from certain conditions.

This drug is being recalled because a Cyclobenzaprine 10 mg (90-count) label was accidentally placed on a bottle containing Meloxicam 7.5 mg tablets. Meloxicam is a nonsteroidal anti-inflammatory drug and is used for the treatment of certain types of arthritis. Meloxicam Tablets, USP, 7.5 mg are light yellow, round, flat, beveled-edged tablets with “U & L” debossed on one side and “7.5” debossed on the other side. Using Meloxicam unknowingly if it is not prescribed for you may cause any of several different serious adverse events—particularly in people taking other nonsteroidal anti-inflammatory drugs or blood thinners, people who have allergies to Meloxicam, or people with underlying illness.

To see if your medication was recalled, contact your doctor or pharmacy where you received it or visit the FDA website below. If you have an affected lot of Cyclobenzaprine, you should stop using the product and return it to the place of purchase. If you have experienced any problems that may be related to taking this product, you should contact your doctor or health care provider.

As of Aug. 27, there had been no reports of adverse events related to this recall.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Inmar at 1-877-840-5109. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. CST.
  • Visit the FDA website.

Recent Announcements

Voluntary nationwide recall: Lactated Ringers and 0.9% Sodium Chloride (B. Braun-Aug)

B. Braun Medical, Inc. is recalling two lots of Lactated Ringers Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL. These are intravenous (IV) fluids commonly used in the hospital to treat dehydration and other conditions.
Aug. 2025Pharmacy Updates

CME Webinar: Evaluating Antimicrobial Stewardship Techniques in the Outpatient Setting

Please join us for a live, CME-accredited webinar on Tuesday, Nov. 4, from noon to 1 p.m. that will share an overview of evaluating antimicrobial stewardship techniques in the outpatient setting.
Aug. 2025Education/Webinars

Understanding available resources for substance misuse and addiction

Information available on the internet can be overwhelming when searching on the topic of substance misuse and addiction. UPMC Health Plan has a dedicated webpage containing information and links to treatment service options, harm reduction services, and other supports. The webpage includes local, state, and national resources to help streamline the search process for members and their families who may be experiencing challenges related to substance misuse and addiction, and for providers who may be looking for information on how to best support their patients.
Aug. 2025Important Notices